ID

29258

Beschrijving

Acetyl-L-Carnitine in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00984750

Link

https://clinicaltrials.gov/show/NCT00984750

Trefwoorden

Versies (1)
  1. 13-03-18 13-03-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

13 maart 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes Type 2 NCT00984750

Engels

Eligibility Diabetes Type 2 NCT00984750

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
males and females >40 years old;
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
high-risk subjects with type 2 diabetes (who criteria);
Beschrijving

Study Subject High risk | Diabetes Mellitus, Non-Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0332167
UMLS CUI [2]
C0011860
high blood pressure (systolic blood pressure >140 mmhg or with concomitant antihypertensive treatment stable since at least 3 months);
Beschrijving

Hypertensive disease | Systolic Pressure | Antihypertensive therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0585941
serum creatinine concentration <1.5 mg/dl;
Beschrijving

Creatinine measurement, serum

Datatype

boolean

Alias
UMLS CUI [1]
C0201976
patients legally able to give written informed consent to the trial (signed and dated by the patient);
Beschrijving

Ability Legal Informed Consent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C1301860
UMLS CUI [1,3]
C0021430
written informed consent.
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
uncontrolled diabetes (glycated hemoglobin >11%);
Beschrijving

Diabetic - poor control | Glucohemoglobin measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0421258
UMLS CUI [2]
C0202054
acute cardiovascular events over the last 3 months;
Beschrijving

Cardiovascular event

Datatype

boolean

Alias
UMLS CUI [1]
C1320716
specific contraindications or history of hypersensitivity to the study drugs;
Beschrijving

Medical contraindication Investigational New Drugs | Hypersensitivity Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013230
previous history of allergy or intolerance, or evidence of immunologically-mediated renal disease, systemic diseases, cancer;
Beschrijving

Hypersensitivity | Intolerance | Kidney Disease Immune system Mediated | Systemic disease Immune system Mediated | Malignant Neoplasms Immune system Mediated

Datatype

boolean

Alias
UMLS CUI [1]
C0020517
UMLS CUI [2]
C0231199
UMLS CUI [3,1]
C0022658
UMLS CUI [3,2]
C0020962
UMLS CUI [3,3]
C0086597
UMLS CUI [4,1]
C0442893
UMLS CUI [4,2]
C0020962
UMLS CUI [4,3]
C0086597
UMLS CUI [5,1]
C0006826
UMLS CUI [5,2]
C0020962
UMLS CUI [5,3]
C0086597
drug or alcohol abuse;
Beschrijving

Substance Use Disorders

Datatype

boolean

Alias
UMLS CUI [1]
C0038586
any chronic clinical conditions that may affect completion of the trial or confound data interpretation;
Beschrijving

Chronic disease Affecting Completion of clinical trial | Chronic disease Interferes with Interpretation Research data

Datatype

boolean

Alias
UMLS CUI [1,1]
C0008679
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C2732579
UMLS CUI [2,1]
C0008679
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0459471
UMLS CUI [2,4]
C0681873
pregnancy or lactating;
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
women of childbearing potential without following a scientifically accepted form of contraception;
Beschrijving

Childbearing Potential Contraceptive methods Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0332197
legal incapacity and/or other circumstances rendering the patient unable to understand the nature, scope and possible consequence of the trial;
Beschrijving

Legal capacity Lacking | Comprehension Study Protocol Unable | Circumstances Comprehension Study Protocol Unable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0683673
UMLS CUI [1,2]
C0332268
UMLS CUI [2,1]
C0162340
UMLS CUI [2,2]
C2348563
UMLS CUI [2,3]
C1299582
UMLS CUI [3,1]
C0680082
UMLS CUI [3,2]
C0162340
UMLS CUI [3,3]
C2348563
UMLS CUI [3,4]
C1299582
evidence of an uncooperative attitude;
Beschrijving

Uncooperative attitude

Datatype

boolean

Alias
UMLS CUI [1]
C2188045
any evidence that patient will not be able to complete the trial follow-up.
Beschrijving

Patient Completion of clinical trial Unable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C2732579
UMLS CUI [1,3]
C1299582
Terug naar het begin van de pagina

Similar models

Eligibility Diabetes Type 2 NCT00984750

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
males and females >40 years old;
boolean
C0001779 (UMLS CUI [1])
Study Subject High risk | Diabetes Mellitus, Non-Insulin-Dependent
Item
high-risk subjects with type 2 diabetes (who criteria);
boolean
C0681850 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2])
Hypertensive disease | Systolic Pressure | Antihypertensive therapy
Item
high blood pressure (systolic blood pressure >140 mmhg or with concomitant antihypertensive treatment stable since at least 3 months);
boolean
C0020538 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0585941 (UMLS CUI [3])
Creatinine measurement, serum
Item
serum creatinine concentration <1.5 mg/dl;
boolean
C0201976 (UMLS CUI [1])
Ability Legal Informed Consent
Item
patients legally able to give written informed consent to the trial (signed and dated by the patient);
boolean
C0085732 (UMLS CUI [1,1])
C1301860 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
Informed Consent
Item
written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetic - poor control | Glucohemoglobin measurement
Item
uncontrolled diabetes (glycated hemoglobin >11%);
boolean
C0421258 (UMLS CUI [1])
C0202054 (UMLS CUI [2])
Cardiovascular event
Item
acute cardiovascular events over the last 3 months;
boolean
C1320716 (UMLS CUI [1])
Medical contraindication Investigational New Drugs | Hypersensitivity Investigational New Drugs
Item
specific contraindications or history of hypersensitivity to the study drugs;
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
Hypersensitivity | Intolerance | Kidney Disease Immune system Mediated | Systemic disease Immune system Mediated | Malignant Neoplasms Immune system Mediated
Item
previous history of allergy or intolerance, or evidence of immunologically-mediated renal disease, systemic diseases, cancer;
boolean
C0020517 (UMLS CUI [1])
C0231199 (UMLS CUI [2])
C0022658 (UMLS CUI [3,1])
C0020962 (UMLS CUI [3,2])
C0086597 (UMLS CUI [3,3])
C0442893 (UMLS CUI [4,1])
C0020962 (UMLS CUI [4,2])
C0086597 (UMLS CUI [4,3])
C0006826 (UMLS CUI [5,1])
C0020962 (UMLS CUI [5,2])
C0086597 (UMLS CUI [5,3])
Substance Use Disorders
Item
drug or alcohol abuse;
boolean
C0038586 (UMLS CUI [1])
Chronic disease Affecting Completion of clinical trial | Chronic disease Interferes with Interpretation Research data
Item
any chronic clinical conditions that may affect completion of the trial or confound data interpretation;
boolean
C0008679 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2732579 (UMLS CUI [1,3])
C0008679 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0459471 (UMLS CUI [2,3])
C0681873 (UMLS CUI [2,4])
Pregnancy | Breast Feeding
Item
pregnancy or lactating;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Childbearing Potential Contraceptive methods Absent
Item
women of childbearing potential without following a scientifically accepted form of contraception;
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Legal capacity Lacking | Comprehension Study Protocol Unable | Circumstances Comprehension Study Protocol Unable
Item
legal incapacity and/or other circumstances rendering the patient unable to understand the nature, scope and possible consequence of the trial;
boolean
C0683673 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
C0162340 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C0680082 (UMLS CUI [3,1])
C0162340 (UMLS CUI [3,2])
C2348563 (UMLS CUI [3,3])
C1299582 (UMLS CUI [3,4])
Uncooperative attitude
Item
evidence of an uncooperative attitude;
boolean
C2188045 (UMLS CUI [1])
Patient Completion of clinical trial Unable
Item
any evidence that patient will not be able to complete the trial follow-up.
boolean
C0030705 (UMLS CUI [1,1])
C2732579 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial